“…For example, CYLD deficiency may cause overexpression of the c-myb oncogene as a feature of cylindromas (Corda and Sala, 2016). However, in addition to NEMO, activated CYLD can remove the lysine 63-linked polyubiquitin chains of BCL-3 (an atypical IκB), thus preventing BCL-3 translocation into the nucleus together with p52 and p50, which may also promote cell proliferation.…”